Dapansutrile clinical trials. 4 days ago · Dapansutrile is an oral NLRP3 inflammasome inhibitor targeting multiple inflammatory indications. This clinical trial investigates the efficacy of Dapansutrile, in comparison to a placebo, for the treatment of acute gout flare, a joint disease causing sudden and severe pain, often in the big toe. Dr Williams-Gray and her clinical team in Cambridge has a great deal of experience researching the role of inflammation in Parkinson’s. It is in late-stage clinical development, with ongoing Phase 2 and 3 trials. The main questions it aims to answer are: is dapansutrile safe and well-tolerated in people with Parkinson's? does dapansutrile reduce inflammation in the brain, cerebrospinal fluid (CSF) and blood? Dapan-Dia | Dapansutrile in Diabetes and Diabetes-Related Complications A Phase 2 Investigator-initiated clinical study in up to 300 patients with type 2 diabetes mellitus (T2D) and diabetes-related complications. Dec 21, 2017 · ICH GCP US Clinical Trials Registry Clinical Trial NCT03534297 Study of Dapansutrile Capsules in Heart Failure January 6, 2020 updated by: Olatec Therapeutics LLC Apr 7, 2020 · Dapansutrile is a specific NLRP3 inflammasome inhibitor with a satisfactory safety profile and efficacy in the reduction of target joint pain in this study. Nov 28, 2022 · To assess the clinical activity of dapansutrile compared to placebo in treating signs and symptoms of an acute gout flare other than pain (tenderness, swelling, erythema, warmth, and range of motion) Change from baseline in the Investigator-assessed Target Joint Score at scheduled assessments through Study Day 15. The DAPAN-DIA Study, a randomised, double-blind, placebo-controlled trial, aims to enrol approximately 300 patients across multiple European centres. Clinical translation is progressing: Dapansutrile has entered Phase I trials in systolic heart failure and MI, while colchicine—an established anti-inflammatory agent now recognized as an NLRP3 inhibitor—has gained FDA approval for cardiovascular indications [166]. Nov 29, 2022 · The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare. sykhod soqqaw aiay bqrbns pdjdr yyz nelxdu fmt hqontna rwdsa